Sony’s Spider-Man Universe has had a rough ride. Most of its spinoff movies, like Venom and Morbius, have been panned by critics, yet Sony keeps producing them. The reason lies in a contract that ties the studio to Spider-Man’s future.
In 1998, Sony acquired the rights to make Spider-Man movies from Marvel. According to a leaked 71-page agreement, Sony must release Spider-Man-related films regularly to keep these rights.
The contract requires Sony to start production on a new movie within 3 years and 9 months of the last release and to release it within 5 years and 9 months.
A History of Hits and Misses
Sony’s first spinoff, Venom, was slammed by critics but grossed $856 million at the box office. Its sequels, however, earned less with each release.
Other spinoffs, like Morbius and Kraven the Hunter, failed to impress both critics and audiences. Kraven earned just $52.9 million, making it the lowest-grossing Spider-Man spinoff.
Despite these setbacks, Sony persists. Its contract with Marvel requires each movie to have a budget of at least $75 million, a PG-13 rating, and a release in at least 2,000 theaters.
Collaboration With Marvel
While Sony controls the Spider-Man movies, Marvel still plays a role. The contract gives Marvel input on major creative decisions, including the cast, director, and script.
However, Sony has the final say. Marvel also shares 25% of the production costs and profits for live-action Spider-Man movies starring Tom Holland.
The Future of Spider-Man at Sony
Sony plans to focus on its animated Spider-Verse movies and live-action Spider-Man films. However, the studio continues to explore new spinoffs, like Noir, a series starring Nicolas Cage as a retro Spider-Man fighting Nazis.
For Sony, the contract ensures Spider-Man stays in its hands. Whether these spinoffs succeed or fail, Sony must keep making them to retain its claim to one of Hollywood’s most iconic heroes.
